![2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[[bis(4-methoxyphenyl)phenylmethoxy]me…](https://static.cymitquimica.com/products/IN/img/DA002F9K.png "Cliccare per ingrandire")
2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-2,3-dihydro-8-methyl-, (2R,3R,5R)-
CAS: 191474-13-2
Rif. IN-DA002F9K
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 24 Marzo 2025
Informazioni sul prodotto
Nome:
2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-2,3-dihydro-8-methyl-, (2R,3R,5R)-
Sinonimi:
- 5'-O-(4,4'-Dimethoxytrityl)-2,3'-anhydrothymidine
- 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2,3'-anhydrothymidine
- 5 inverted exclamation mark -O-(4,4 inverted exclamation mark -Dimethoxytrityl)-2,3 inverted exclamation mark -anhydrothymidine
- 2,3'-anhydro-5'-O-(4,4'-dimethoxytrityl)thymidine
- 2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[4,4'-dimethoxtrityl]-2,3-dihydro-8-methyl-, (2R,3R,5R)-
- Anhydrothymidine-FLT-precursor
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)phenylmethoxy]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- Vedi altri sinonimi
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- 5'-O-(4,4'-dimethoxytrityl)-2,3'-anhydrothymidine
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- (2R,3R,5R)-3-[[Bis(4-methoxyphenyl)
- phenylmethox-y]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one
- 2,5-Methano-5H,9H-pyrimidol[2,1-b][1,5,3]dioxazepin-9-one,
- 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-meth-yl,(2R,3R,5R)-
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
526.5797
Formula:
C31H30N2O6
Colore/Forma:
Solid
InChI:
InChI=1S/C31H30N2O6/c1-20-18-33-28-17-26(39-30(33)32-29(20)34)27(38-28)19-37-31(21-7-5-4-6-8-21,22-9-13-24(35-2)14-10-22)23-11-15-25(36-3)16-12-23/h4-16,18,26-28H,17,19H2,1-3H3/t26-,27+,28+/m0/s1
InChI key:
SWDIHODJLJEUEJ-UPRLRBBYSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
Richiesta tecnica su: IN-DA002F9K 2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-2,3-dihydro-8-methyl-, (2R,3R,5R)-
Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
